McAfee Foundation funds Preclinical Therapeutic Study for Alveolar Rhabdomyosarcoma

We are grateful to the Joanna McAfee Childhood Cancer Foundation for their 2nd grant in amount of $8,538 to evaluate a novel new compound for efficacy in a genetically-engineered mouse model of alveolar rhabdomyosarcoma.  This study is done as part of the Pediatric Preclinical Testing Initiative at the our institution... an effort to speed discovery of clinically-feasible agents that can be moved to clinical trials for childhood cancer.


To learn more about JMCCF, and Joanna's & her family's story, click here.